First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study. [electronic resource]
Producer: 20180815Description: 13-20 p. digitalISSN:- 2589-0409
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.